With the prevalence of end stage renal disease steadily increasing, chronic kidney disease
(CKD) represents an impending public healthcare challenge. Classical diagnostic …

Chronic kidney disease (CKD) remains a major challenge in nephrology and for public
health care, affecting 14% to 15% of the adult US population and consuming significant …

Background Chronic kidney disease (CKD) is recognised as a global public health problem,
more prevalent in older persons and associated with multiple co-morbidities. Diabetes …

The era of 'evidence-based medicine'emphasized the need for robust evidence to ensure
that treatments afford benefit with limited or acceptable levels of harm, but neglected …

Globally, chronic kidney disease (CKD) contributes substantial morbidity and mortality.
Recently, various 'omics platforms have provided insight into the molecular basis of kidney …

Chronic kidney diseases (CKDs) are currently classified according to their clinical features,
associated comorbidities and pattern of injury on biopsy. Even within a given classification …

The goal of “precision medicine” is to characterize diseases based on the underlying
molecular biology, in order to identify specific biomarkers and therapeutic targets that will …

Current classification of chronic kidney disease (CKD) into stages based on the indirect
measures of kidney functional state, estimated glomerular filtration rate and albuminuria, is …

Chronic kidney disease (CKD) has shown an increasing prevalence in the last century. CKD
encompasses a poor prognosis related to a remarkable number of comorbidities, and many …

Discovery of novel improved tools for diagnosis, prevention and therapy of chronic kidney
disease (CKD) is an important task for the nephrology community and it is likely that …